Fig. 1From: Most of anti-glycolipid IgG-antibodies associated to neurological disorders occur without their IgM counterpartReactivity of IgM- and IgG-antibodies against glycolipid self and non-self glycans. Representative results of the anti-non-self glycan and anti-self glycan immunoreactivity in (a) normal human sera and in (b) neurological disorder patients. On the left are glycolipids visualized using orcinol reagentBack to article page